Bicara Therapeutics Inc. (BCAX) Balance Sheet
As of 2026-06-30 (10-Q), Bicara Therapeutics Inc. (BCAX) reported total assets of $512.2M, total liabilities of $43.5M and shareholders' equity of $468.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $96.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BCAXBicara Therapeutics Inc.Follow BCAX — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|
| Cash and equivalents | 489.7 | 96.7 | 96.6 | |
| Short-term investments | 0.0 | 318.1 | 400.7 | |
| Current assets | 502.5 | 422.1 | 503.8 | |
| Total assets | 510.0 | 431.0 | 512.2 | |
| Current liabilities | 18.0 | 28.9 | 43.5 | |
| Total liabilities | 18.1 | 29.5 | 43.5 | |
| Shareholders' equity | 491.9 | 401.5 | 468.8 |
USD millions · SEC XBRL
Bicara Therapeutics Inc. — questions
- How much cash does Bicara Therapeutics Inc. have?
- $96.6M in cash and cash equivalents as of 2026-06-30.
- What are Bicara Therapeutics Inc.'s total assets?
- $512.2M as of 2026-06-30.
- What is Bicara Therapeutics Inc.'s shareholders' equity?
- $468.8M as of 2026-06-30.
Every figure on this page comes from Bicara Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.